ROCKET PHARMACEUTICALS, INC.·4

Jul 18, 4:05 PM ET

WONG RODERICK 4

4 · ROCKET PHARMACEUTICALS, INC. · Filed Jul 18, 2025

Insider Transaction Report

Form 4
Period: 2025-06-18
WONG RODERICK
Director10% Owner
Transactions
  • Award

    Common Stock

    2025-06-18+30,00030,000 total
  • Award

    Common Stock

    2025-06-18+17,66747,667 total
Holdings
  • Common Stock

    (indirect: See footnote)
    18,188,457
Footnotes (3)
  • [F1]Represents restricted stock units ("RSUs") that convert to common stock on a one-for-one basis. The RSUs will vest in full on June 18, 2026.
  • [F2]Represents RSUs issued to the Reporting Person in lieu of director retainer fees of $50,000. The RSUs will vest in full on June 18, 2026.
  • [F3]Represents shares held by certain investment funds managed by RTW Investments, LP (the "Adviser"). The Reporting Person serves as the Managing Partner and Chief Investment Officer of the Adviser and is a director of the Issuer and Chairman of the Issuer's Board of Directors.

Documents

1 file
  • 4
    form4.xmlPrimary

    FORM 4